Clobetasol propionate - Promius Pharma

Drug Profile

Clobetasol propionate - Promius Pharma

Alternative Names: DFD 06; Impoyz

Latest Information Update: 03 May 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Promius Pharma
  • Developer Encore Dermatology; Promius Pharma
  • Class Anti-inflammatories; Antipsoriatics; Fluorinated steroids; Glucocorticoids
  • Mechanism of Action Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Plaque psoriasis

Most Recent Events

  • 01 May 2018 Launched for Plaque psoriasis (In adults) in USA (Topical)
  • 06 Dec 2017 Chemical structure information added
  • 28 Nov 2017 Registered for Plaque psoriasis in USA (Topical) - First Global Approval
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top